Trade Summary

2 months ago, Chesed Abraham, serving as Board Observer at Turn Therapeutics Inc. (TTRX), purchased 14,286 shares at $4.60 per share, for a total transaction value of $65,716.00. Following this transaction, Chesed Abraham now holds 1,447,268 shares of TTRX.

This purchase represents a 1.00% increase in Chesed Abraham's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, October 23, 2025 and publicly disclosed via SEC Form 4 filing on Wednesday, October 29, 2025, 6 days after the trade was made.

Turn Therapeutics Inc. operates in the NONE sector, specifically within the NONE industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.